Zadnji put ažurirano :
19/11/2024
antifungicid   Amphotericin B lipid complex  
injekcija
Stabilizacija rješenja Stabilnost mješavine Stabilizacijski faktor Kompatibilnosti način davanja lijeka Bibliografija pdf
   Kemijska struktura  

Nekomercijalni   Nekomercijalni     

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Abelcet Argentina, Australija, Austrija, Belgija, Brazil, Danska, Finska, Francuska, Grčka, Irska, Italija, Kanada, Luksemburg, Madžarska, Malezija, Meksiko, Nizozemska, Njemačka, Norveška, Peru, Portugal, Rumunjska, S A D, Španjolska, Švedska, Velika Britanija
Bibliografija   injekcija   Bibliografija : Amphotericin B lipid complex  
Vrsta Publikacija
1510 knjiga AHFS Formulary service 2000 Bethesda - 3546 p
2247 Časopis Chan P, Heatherly K, Kupiec T.C, Trissel L.A.
Compatibility of caspofungin acetate injection with other drugs during simulated Y-site coadministration.
Int J Pharm Compound 2008 ; 12, 3: 276-278.
2262 Časopis Brammer MK, Chan P, Heatherly K, Trusley C, Kupiec TC, Trissel LA, Psathas PA, Gilmor T, Schaufelberger D.
Compatibility of doripenem with other drugs during simulated Y-site administratioN
Am J Health-Syst Pharm 2008 ; 65: 1261-1265.
3254 Časopis Housman S.T, Tessier P.R, Nicolau D.P, Kuti J.L.
Physical compatibility of telavancin hydrochloride with select i.v. drugs during simulated Y-site administration
Am J Health-Syst Pharm 2011 ; 68: 2265-2270.
3332 Laboratorija Tigecycline (Tigacyl®) - Summary of Product characteristics
Pfizer 2012
3644 Laboratorija Calcium gluconate® - Summary of Product Characteristics
Hameln Pharmaceuticals 2010
3828 Plakat Thabit A.K, Hamada Y, Nicolau D.P.
Ceftozolane/tazobactam physical compatibility during simulated Y-site administration.
ASHP Midyear 2015
3829 Plakat So W, Kim L, Thabit A.K, Nicolau D.P, Kuti J.L.
Compatibility of isavunazonium sulfate during simulated Y-site administration.
ASHP Midyear 2015
4055 Časopis Monogue M, Almarzoky Abuhussain S, Kuti J, Nicolau D.
Physical compatibility of fosfomycin for injection with select i.v. drugs during simulated Y-site administration.
Am J Health-Syst Pharm 2018 , 75, 1:36-44

  Mentions Légales